Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?
Corkum MT, Mitchell S, Venkatesan V, Read N, Warner A, Palma DA.
Adv Radiat Oncol. 2019 Jun 12;4(4):683-688. doi: 10.1016/j.adro.2019.06.001. eCollection 2019 Oct-Dec.
PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Domínguez-Franjo P, Piris MA.
Am J Surg Pathol. 2008 Aug;32(8):1252-7. doi: 10.1097/PAS.0b013e318165b0d6.
A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.
Teknos TN, Grecula J, Agrawal A, Old MO, Ozer E, Carrau R, Kang S, Rocco J, Blakaj D, Diavolitsis V, Kumar B, Kumar P, Pan Q, Palettas M, Wei L, Baiocchi R, Savvides P.
Invest New Drugs. 2019 Aug;37(4):702-710. doi: 10.1007/s10637-018-0696-4. Epub 2018 Dec 19.
[Palliative demolitive surgery].
Caldarola L, Badellino F, Santoro L, Cardone B.
Minerva Med. 1975 May 9;66(35):1668-82.
Retromolar trigone--oropharynx junction maligns tumor surgery: transmandibular versus oral approach.
Cobzeanu BM, Popescu E, Costan VV, Ungureanu D, Cobzeanu MD.
Rev Med Chir Soc Med Nat Iasi. 2015 Jan-Mar;119(1):119-26.
